The EU General Court thrashed the company's appeal against the European Commission’s decision to impose a penalty on Unichem in the perindopril patent case. The company is reviewing the judgement and might appeal before the European Court of Justice.

Market participants had expected SEBI to allow mutual funds to practice side-pocketing and it is now official granted. Read on to know more.

Following stocks are close to their 52-week low as at 12.34 p.m. on December 13, 2018.

The markets on December 13, 2018 opened gap up. BSE Sensex is trading at 35,949.89, up by 170.82 points and the Nifty is trading at 10,793.40, up by 55.80 points. 

Strides Pharma’s step-down wholly-owned subsidiary, Strides Pharma Globe Pte. Limited, Singapore, received USFDA approval for Lidocaine Ointment. The stocks of Strides gained 2 per cent in the morning trading session.

The company has received appointment date from the National Highways Authority of India (NHAI) for an EPC project worth Rs. 981 crore in Uttar Pradesh. 

Overall volumes in futures & options currently stand at 1.67 crore contracts with a turnover of Rs. 9,56,463.76 crore.

Overall volumes in futures & options currently stand at 1.67 crore contracts with a turnover of Rs. 9,56,463.76 crore.

It would be important for the Nifty to surpass its 200-day moving average and trade above this zone for extending its rally. Sustaining above the 200-day moving average will open up for upmove towards the levels of 10,840-10,890. Stocks in news: Lupin, Stride Pharma Science, Pricol, Sadbhav Engineering and Punjab & Sind Bank.

Today, the markets are likely to make an optimistic start, tracking positive trend among Asian peers and a positive close on Wall Street overnight. Traders will be getting some encouragement with the data released yesterday post-market, reflecting economy's improved performance as retail inflation eased to 2.3 per cent while IIP grew at an 11-month high of 8.1 per cent. The SGX Nifty is currently trading at 10,840 level, up by 52 points.